Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
Read More…
Industry, Sector and Symbol
Industry Management consulting services
Sub-IndustryResearch & Consulting Services
SectorBusiness Services
Phone650-326-9400
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$379.52 million
Profitability
Miscellaneous
Employees1,122
Next Earnings Date1/30/2020 (Estimated)
OptionableOptionable
Exponent (NASDAQ:EXPO) Frequently Asked Questions
What is Exponent's stock symbol?
Exponent trades on the NASDAQ under the ticker symbol "EXPO."
How often does Exponent pay dividends? What is the dividend yield for Exponent?
Exponent declared a quarterly dividend on Thursday, July 18th. Investors of record on Friday, September 6th will be paid a dividend of $0.16 per share on Friday, September 20th. This represents a $0.64 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, September 5th. View Exponent's Dividend History.
When did Exponent's stock split? How did Exponent's stock split work?
Exponent's stock split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were payable to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.
How were Exponent's earnings last quarter?
Exponent, Inc. (NASDAQ:EXPO) posted its quarterly earnings data on Thursday, October, 17th. The business services provider reported $0.36 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.34 by $0.02. The business services provider earned $101.50 million during the quarter, compared to analyst estimates of $100.17 million. Exponent had a net margin of 19.88% and a return on equity of 24.13%. The business's revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.32 EPS. View Exponent's Earnings History.
When is Exponent's next earnings date?
What price target have analysts set for EXPO?
5 brokers have issued 12 month price objectives for Exponent's stock. Their predictions range from $72.00 to $81.00. On average, they anticipate Exponent's stock price to reach $75.33 in the next twelve months. This suggests a possible upside of 14.8% from the stock's current price. View Analyst Price Targets for Exponent.
What is the consensus analysts' recommendation for Exponent?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Exponent.
Has Exponent been receiving favorable news coverage?
News stories about EXPO stock have been trending somewhat negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Exponent earned a coverage optimism score of -1.5 on InfoTrie's scale. They also assigned news articles about the business services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Exponent.
Are investors shorting Exponent?
Exponent saw a decline in short interest in the month of September. As of September 30th, there was short interest totalling 579,800 shares, a decline of 13.3% from the August 30th total of 668,600 shares. Based on an average daily volume of 290,300 shares, the days-to-cover ratio is currently 2.0 days. Currently, 1.1% of the shares of the stock are sold short. View Exponent's Current Options Chain.
Who are some of Exponent's key competitors?
Some companies that are related to Exponent include Booz Allen Hamilton (BAH), Genpact (G), FTI Consulting (FCN), ICF International (ICFI), RMR Group (RMR), NIC (EGOV), Huron Consulting Group (HURN), Navigant Consulting (NCI), Gopher Protocol (GOPH), Apollo Medical (AMEH), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III) and ATIF (ATIF).
What other stocks do shareholders of Exponent own?
Who are Exponent's key executives?
Exponent's management team includes the folowing people:
- Dr. Paul R. Johnston, Exec. Chairman (Age 65)
- Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 50)
- Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 53)
- Dr. Harri K. Kytomaa, Group VP & Principal Engineer (Age 60)
- Dr. Steven J. Murray, Group VP & Principal Engineer (Age 44)
Who are Exponent's major shareholders?
Exponent's stock is owned by many different of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (1.09%), Envestnet Asset Management Inc. (0.31%), State of Alaska Department of Revenue (0.08%), Avitas Wealth Management LLC (0.03%), Cordasco Financial Network (0.03%) and CIBC Private Wealth Group LLC (0.03%). Company insiders that own Exponent stock include Carol Lindstrom, Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Institutional Ownership Trends for Exponent.
Which major investors are selling Exponent stock?
EXPO stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Envestnet Asset Management Inc., Crossmark Global Holdings Inc., Clarus Wealth Advisors and Cordasco Financial Network. Company insiders that have sold Exponent company stock in the last year include Carol Lindstrom, Harri Kytomaa, John Pye and Richard L Schlenker Jr. View Insider Buying and Selling for Exponent.
Which major investors are buying Exponent stock?
EXPO stock was acquired by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Assenagon Asset Management S.A., Campbell & CO Investment Adviser LLC, Avitas Wealth Management LLC, Park Avenue Securities LLC, CIBC Private Wealth Group LLC and Nisa Investment Advisors LLC. View Insider Buying and Selling for Exponent.
How do I buy shares of Exponent?
Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Exponent's stock price today?
One share of EXPO stock can currently be purchased for approximately $65.63.
How big of a company is Exponent?
Exponent has a market capitalization of $3.41 billion and generates $379.52 million in revenue each year. The business services provider earns $72.25 million in net income (profit) each year or $1.25 on an earnings per share basis. Exponent employs 1,122 workers across the globe.View Additional Information About Exponent.
What is Exponent's official website?
How can I contact Exponent?
Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]
MarketBeat Community Rating for Exponent (NASDAQ EXPO)
MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote "Outperform" if you believe EXPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
